CRCA vs. SPOG
CRCA (ProShares Ultra CRCL) and SPOG (Leverage Shares 2X Long SPOT Daily ETF) are both Leveraged Equities funds. Both are actively managed. At a 0.21 correlation, their price movements are largely independent. CRCA charges 0.95%/yr vs 0.75%/yr for SPOG.
Performance
CRCA vs. SPOG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -25.12% return, which is significantly higher than SPOG's -40.37% return.
CRCA
- 1D
- 0.33%
- 1M
- -42.95%
- YTD
- -25.12%
- 6M
- -41.42%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SPOG
- 1D
- 1.97%
- 1M
- 33.09%
- YTD
- -40.37%
- 6M
- -36.60%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
CRCA vs. SPOG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -25.12% | -2.63% |
SPOG Leverage Shares 2X Long SPOT Daily ETF | -40.37% | -19.53% |
Correlation
The correlation between CRCA and SPOG is 0.21, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 18, 2025 | 0.21 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. SPOG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Leverage Shares 2X Long SPOT Daily ETF (SPOG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | SPOG | Difference | |
|---|---|---|---|
Sharpe Ratio (All Time)Calculated using the full available price history | -0.47 | -0.72 | +0.26 |
Drawdowns
CRCA vs. SPOG - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, which is greater than SPOG's maximum drawdown of -64.41%. Use the drawdown chart below to compare losses from any high point for CRCA and SPOG.
Loading charts...
Drawdown Indicators
| CRCA | SPOG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -64.41% | -29.61% |
Current DrawdownCurrent decline from peak | -87.94% | -52.02% | -35.92% |
Average DrawdownAverage peak-to-trough decline | -69.35% | -40.51% | -28.84% |
Volatility
CRCA vs. SPOG - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | SPOG | Difference | |
|---|---|---|---|
Volatility (1Y)Calculated over the trailing 1-year period | 196.32% | 103.50% | +92.82% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.32% | 103.50% | +92.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.32% | 103.50% | +92.82% |
CRCA vs. SPOG - Expense Ratio Comparison
CRCA has a 0.95% expense ratio, which is higher than SPOG's 0.75% expense ratio.
Dividends
CRCA vs. SPOG - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 2.31%, while SPOG has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
CRCA ProShares Ultra CRCL | 2.31% | 1.06% |
SPOG Leverage Shares 2X Long SPOT Daily ETF | 0.00% | 0.00% |
Frequently Asked Questions
CRCA and SPOG have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SPOG is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SPOG is cheaper with a 0.75% expense ratio, compared with 0.95% for CRCA.
CRCA has the higher dividend yield at 2.31%, compared with 0.00% for SPOG.
They also come from different issuers: ProShares and Leverage Shares. Their fees differ too: 0.95% for CRCA and 0.75% for SPOG.
Find the right allocation for CRCA and SPOG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer